10-Q · May 8, 2026
Exponent, Inc. reported strong Q1 2026 results with revenue increasing by 14% year-over-year to $166.3 million, exceeding expectations. Diluted EPS rose to $0.59, an increase of 13.5% from the prior year, despite a…
Earnings analysis · 10-Q
EXPO earnings analysis
Filed August 7, 2026 · Our reading of the company's report
The latest report
Exponent delivered strong second-quarter growth, with revenue of $171.612 million up 12.9% sequentially and 20.9% year over year, while diluted EPS rose to $0.60 from $0.59 and $0.52, respectively. Revenue and EPS…
Read full summary
Exponent delivered strong second-quarter growth, with revenue of $171.612 million up 12.9% sequentially and 20.9% year over year, while diluted EPS rose to $0.60 from $0.59 and $0.52, respectively. Revenue and EPS exceeded consensus estimates, although the provided filing text does not disclose current operating margin, free cash flow, segment results or quantitative forward guidance. Risk factors were stated to have no material changes from the 2025 Annual Report, while international operations continue to create unhedged foreign-exchange exposure.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.6
- Gross margin
- 100.0%
What stood out
-
Strong Revenue Acceleration
Second-quarter revenue was $171.612 million, up from $152 million in Q1 2026 and $142 million in Q2 2025, increases of approximately 12.9% sequentially and 20.9% year over year.
-
EPS Improved
Diluted EPS was $0.60, versus $0.59 in Q1 2026 and $0.52 in Q2 2025, representing a $0.01 sequential increase and a $0.08 year-over-year increase.
-
Material Revenue Beat
Revenue exceeded the $146.805 million consensus estimate by $24.807 million, or 16.9%, while EPS of $0.60 exceeded the $0.59 estimate by $0.01.
-
Gross Margin Maintained
Gross margin remained 100.0% in the reported quarter, consistent with the quarterly financial history provided.
-
Share Repurchases Continued
The company repurchased 1,125 thousand shares during the three months ended July 3, 2026, at an average price of $59.88 per share.
-
Expanded Capital Return
The board had approved $150 million of cumulative share-repurchase authorization: $100 million on October 30, 2025 and an additional $50 million on April 30, 2026.
What to watch
-
International FX Exposure
Foreign-exchange exposure includes approximately $12.5 million of net assets denominated in British pounds, $2.8 million in Chinese yuan, $2.8 million in Hong Kong dollars and $1.8 million in Singapore dollars as of July 3, 2026.
-
Unhedged Currency Risk
The company reported approximately $2.7 million of net assets denominated in non-functional currencies at July 3, 2026 and does not use foreign-exchange contracts to hedge these exposures.
-
Interest-Rate Exposure
Cash-equivalent investments have a maximum effective maturity of three years and a maximum average effective maturity of 12 months; a 100-basis-point rate move was not expected to materially affect fair value, but fluctuations could still affect investment returns.
Management's outlook
The filing does not provide quantitative revenue or EPS guidance; no updated outlook was identified in the provided MD&A text.
Earlier filings 4
10-K · February 27, 2026
Exponent describes a diversified, technical consulting firm operating 17 practices across two reportable segments (Engineering and Other Scientific; Environmental and Health) that delivered modest revenue growth to…
10-Q · November 7, 2025
Exponent reported third-quarter 2025 revenue of $147.12M, up versus both the prior quarter and prior-year quarter, with diluted EPS of $0.55 and operating income of $29.04M. Cash declined materially (to $207.38M)…
10-Q · August 8, 2025
Q2 2025 revenue of $141.96M was up modestly vs prior-year quarter and beat the consensus; diluted EPS was $0.52 (in line with the reported actual) but down from $0.57 a year ago. Operating income and operating margin…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.